BILE DUCT CANCER side effect
What is BILE DUCT CANCER ?Drugs associated with BILE DUCT CANCER
ABATACEPT AGRYLIN AVONEX BYETTA CRESTOR DIANEAL ENBREL LANTUS LAPATINIB MENOSTAR METFORMIN METHOTREXATE METHOXY MICARDIS MIRTAZAPINE PROPECIA SIMVASTATIN VESICARE WARFARIN ZOCOR ZYRTECBILE DUCT CANCER : Methoxy Side Effects Report #5620146-X
Physician from JAPAN reported METHOXY POLYETHYLENE GLYCOL problem on Jan 30, 2008. Male patient, 69 years of age, weighting 99.87 lb, was treated with METHOXY POLYETHYLENE GLYCOL. After drug was administered, patient experienced the following problems/side effects: bile duct cancer, . METHOXY POLYETHYLENE GLYCOL dosage: unknown. During the same period patient was treated with METHOXY POLYETHYLENE GLYCOL, METHOXY POLYETHYLENE GLYCOL, METHOXY POLYETHYLENE GLYCOL, ADALAT, AMLODIPINE BESYLATE, ALFAROL, OLMETEC, CARDENALIN. Patient was hospitalized. Patient recovered.
BILE DUCT CANCER : Enbrel Side Effects Report #5621534-8
ENBREL problem was reported by a Consumer or non-health professional from SLOVAKIA (Slovak Republic) on Jan 28, 2007. Female patient, 64 years of age, was diagnosed with rheumatoid arthritis, hypertension, diabetes mellitus and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: bile duct cancer, intestinal haemorrhage, pancreatic carcinoma, red blood cell sedimentation rate increased, . ENBREL dosage: unknown. During the same period patient was treated with MELOXICAM, OMEPRAZOLE, PLENDIL, AMARYL, PREDNISONUM, BISOPROLOL FUMARATE. Patient was hospitalized. Patient died on 08/02/2006.
BILE DUCT CANCER : Vesicare Side Effects Report #5635670-3
Physician from JAPAN reported VESICARE problem on Feb 12, 2008. Female patient, 87 years of age, weighting 99.21 lb, was diagnosed with hypertonic bladder and was treated with VESICARE. After drug was administered, patient experienced the following problems/side effects: bile duct cancer, pancreatic carcinoma, urine output decreased, . VESICARE dosage: 5 MG, UID/QD, ORAL. During the same period patient was treated with MERISLON, OMEPRAZOLE, SERMION. Patient was hospitalized. Patient recovered.
BILE DUCT CANCER : Byetta Side Effects Report #5636606-1
BYETTA problem was reported by a Health Professional from UNITED STATES on Feb 19, 2008. Male patient, 56 years of age, weighting 240.0 lb, was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: bile duct cancer, hepatic neoplasm malignant, . BYETTA dosage: unknown. Patient recovered.
BILE DUCT CANCER : Lapatinib Side Effects Report #5580267-7
Physician from GERMANY reported LAPATINIB problem on Dec 24, 2007. Female patient, 55 years of age, weighting 147.7 lb, was treated with LAPATINIB. After drug was administered, patient experienced the following problems/side effects: bile duct cancer, cholestasis, hyperbilirubinaemia, jaundice, . LAPATINIB dosage: 1250MG PER DAY. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient recovered.
BILE DUCT CANCER : Methoxy Side Effects Report #5596025-3
METHOXY POLYETHYLENE GLYCOL problem was reported by a Physician from JAPAN on Jan 07, 2008. Male patient, 69 years of age, weighting 99.87 lb, was treated with METHOXY POLYETHYLENE GLYCOL. After drug was administered, patient experienced the following problems/side effects: bile duct cancer, . METHOXY POLYETHYLENE GLYCOL dosage: unknown. During the same period patient was treated with METHOXY POLYETHYLENE GLYCOL, METHOXY POLYETHYLENE GLYCOL, METHOXY POLYETHYLENE GLYCOL, ADALAT, AMLODIPINE BESYLATE, ALFAROL, OLMESARTAN MEDOXOMIL, DOXAZOSIN MESYLATE. Patient recovered.
BILE DUCT CANCER : Methoxy Side Effects Report #5604487-8
Physician from JAPAN reported METHOXY POLYETHYLENE GLYCOL problem on Jan 17, 2008. Male patient, 69 years of age, weighting 99.87 lb, was treated with METHOXY POLYETHYLENE GLYCOL. After drug was administered, patient experienced the following problems/side effects: bile duct cancer, . METHOXY POLYETHYLENE GLYCOL dosage: unknown. During the same period patient was treated with METHOXY POLYETHYLENE GLYCOL, METHOXY POLYETHYLENE GLYCOL, METHOXY POLYETHYLENE GLYCOL, ADALAT, AMLODIPINE BESYLATE, ALFAROL, OLMESARTAN MEDOXOMIL, DOXAZOSIN MESYLATE. Patient recovered.
BILE DUCT CANCER : Enbrel Side Effects Report #5536729-1
ENBREL problem was reported by a Physician from UNITED STATES on May 07, 2007. Female patient, weighting 134.0 lb, was diagnosed with psoriatic arthropathy and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: bile duct cancer, cardiac murmur, . ENBREL dosage: unknown. During the same period patient was treated with METHOTREXATE, PRAVACHOL, FOLIC ACID. Patient was hospitalized. Patient recovered.
BILE DUCT CANCER : Propecia Side Effects Report #5538236-9
Physician from JAPAN reported PROPECIA problem on Nov 30, 2007. Male patient, 57 years of age, weighting 154.3 lb, was diagnosed with male pattern baldness, hyperuricaemia and was treated with PROPECIA. After drug was administered, patient experienced the following problems/side effects: bile duct cancer, liver disorder, . PROPECIA dosage: unknown. During the same period patient was treated with ZYLORIC, DIOVAN. Patient was hospitalized. Patient recovered.
BILE DUCT CANCER : Agrylin Side Effects Report #5565841-6
AGRYLIN problem was reported by a Health Professional from CANADA on Dec 11, 2007. Male patient, 59 years of age, was treated with AGRYLIN. After drug was administered, patient experienced the following problems/side effects: bile duct cancer, . AGRYLIN dosage: 4 MG DAILY, ORAL. During the same period patient was treated with ATENOLOL, ASPIRIN, HYDROCHLOROTHIAZIDE, LIPITOR, LISINOPRIL, NORVASC. Patient died.
BILE DUCT CANCER : Propecia Side Effects Report #5569935-0
Physician from JAPAN reported PROPECIA problem on Dec 14, 2007. Male patient, 57 years of age, weighting 154.3 lb, was diagnosed with male pattern baldness, hyperuricaemia and was treated with PROPECIA. After drug was administered, patient experienced the following problems/side effects: bile duct cancer, liver disorder, . PROPECIA dosage: unknown. During the same period patient was treated with ZYLORIC, DIOVAN. Patient was hospitalized. Patient recovered.
BILE DUCT CANCER : Crestor Side Effects Report #5521221-0
CRESTOR problem was reported by a Physician from FINLAND on Nov 12, 2007. Female patient was treated with CRESTOR. After drug was administered, patient experienced the following problems/side effects: bile duct cancer, . CRESTOR dosage: unknown. During the same period patient was treated with LINATIL, PRIMASPAN. Patient was hospitalized. Patient recovered.
BILE DUCT CANCER : Mirtazapine Side Effects Report #5402818-5
Consumer or non-health professional from UNITED KINGDOM reported MIRTAZAPINE problem on July 17, 2007. Female patient, 47 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: bile duct cancer, . MIRTAZAPINE dosage: 30 MG, ORAL. During the same period patient was treated with ESCITALOPRAM OXALATE, LANSOPRAZOLE, METOCLOPRAMIDE. Patient recovered.
BILE DUCT CANCER : Dianeal Side Effects Report #5496731-5
DIANEAL problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 18, 2007. Male patient, 68 years of age, was diagnosed with peritoneal dialysis and was treated with DIANEAL. After drug was administered, patient experienced the following problems/side effects: bile duct cancer, . DIANEAL dosage: unknown. During the same period patient was treated with EXTRANEAL. Patient died.
BILE DUCT CANCER : Avonex Side Effects Report #5501297-7
Consumer or non-health professional from UNITED STATES reported AVONEX problem on Oct 15, 2007. Female patient, 48 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: bile duct cancer, blood albumin decreased, dehydration, dizziness, hepatic neoplasm malignant, hypotension, sepsis, urinary tract infection, . AVONEX dosage: unknown. During the same period patient was treated with AMANTADINE, COZAAR, ANTIVERT, ALAVERT, LASIX, CYMBALTA, THYROID MED. Patient was hospitalized. Patient recovered.
BILE DUCT CANCER : Micardis Side Effects Report #5451633-5
MICARDIS problem was reported by a Consumer or non-health professional from JAPAN on Sept 10, 2007. Male patient, weighting 160.9 lb, was diagnosed with hypertension and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: bile duct cancer, . MICARDIS dosage: unknown. Patient recovered.
BILE DUCT CANCER : Mirtazapine Side Effects Report #5411316-4
Consumer or non-health professional from UNITED KINGDOM reported MIRTAZAPINE problem on July 16, 2007. Female patient, 47 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: bile duct cancer, . MIRTAZAPINE dosage: 30 MG (30 MG, 1 IN 1 D) ORAL. During the same period patient was treated with ESCITALOPRAM OXALATE, LANSOPRAZOLE, METOCLOPRAMIDE. Patient recovered.
BILE DUCT CANCER : Menostar Side Effects Report #5420083-X
MENOSTAR problem was reported by a Health Professional from DENMARK on Aug 08, 2007. Female patient, 69 years of age, was treated with MENOSTAR. After drug was administered, patient experienced the following problems/side effects: bile duct cancer, . MENOSTAR dosage: E2: 0.014 MG/DAY. Patient was hospitalized. Patient recovered.
BILE DUCT CANCER : Lantus Side Effects Report #5422292-2
Physician from AUSTRALIA reported LANTUS problem on Aug 15, 2007. Male patient, 75 years of age, was diagnosed with agitation and was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: bile duct cancer, . LANTUS dosage: unknown. During the same period patient was treated with AUTOPEN INSULINECTION PEN, RISPERDAL, MORPHINE SULPHATE, SERENACE, MAXOLON. Patient died on 07/08/2007.
BILE DUCT CANCER : Warfarin Side Effects Report #5442540-2
WARFARIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 28, 2007. Male patient was diagnosed with coagulopathy and was treated with WARFARIN. After drug was administered, patient experienced the following problems/side effects: bile duct cancer, . WARFARIN dosage: unknown. Patient died on 08/11/2007.
BILE DUCT CANCER : Avonex Side Effects Report #5443125-4
Consumer or non-health professional from UNITED STATES reported AVONEX problem on Aug 22, 2007. Female patient, 48 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: bile duct cancer, dehydration, dizziness, hepatic neoplasm malignant, hypotension, sepsis, urinary tract infection, . AVONEX dosage: unknown. During the same period patient was treated with AMANTADINE, COZAAR, ANTIVERT, ALAVERT, LASIX, CYMBALTA, THYROID MED. Patient was hospitalized. Patient recovered.
BILE DUCT CANCER : Lapatinib Side Effects Report #5380794-1
LAPATINIB problem was reported by a Physician from GERMANY on June 28, 2007. Female patient, 55 years of age, weighting 147.7 lb, was treated with LAPATINIB. After drug was administered, patient experienced the following problems/side effects: bile duct cancer, cholestasis, hyperbilirubinaemia, jaundice, . LAPATINIB dosage: 1250MG PER DAY. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient recovered.
BILE DUCT CANCER : Enbrel Side Effects Report #5385915-2
Physician from GERMANY reported ENBREL problem on July 04, 2007. Female patient, weighting 198.4 lb, was diagnosed with rheumatoid arthritis and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: bile duct cancer, femoral neck fracture, heparin-induced thrombocytopenia, multi-organ failure, pancreatitis necrotising, pancytopenia, pyrexia, sepsis, ventricular fibrillation, . ENBREL dosage: unknown. During the same period patient was treated with METHOTREXATE, PREDNISOLONE, MARCUMAR, BISOPROLOL, XIPAMIDE, MORPHINE. Patient was hospitalized. Patient died on 03/19/2007.
BILE DUCT CANCER : Mirtazapine Side Effects Report #5395628-9
MIRTAZAPINE problem was reported by a Health Professional from UNITED KINGDOM on July 17, 2007. Female patient, 41 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: bile duct cancer, . MIRTAZAPINE dosage: 30 MG QD ORAL. During the same period patient was treated with ESCITALOPRAM OXALATE, LANSOPRAZOLE, METOCLOPRAMIDE. Patient recovered.
BILE DUCT CANCER : Methotrexate Side Effects Report #5396850-8
Consumer or non-health professional from FINLAND reported METHOTREXATE problem on July 24, 2007. Female patient, 52 years of age, was diagnosed with psoriatic arthropathy and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: bile duct cancer, parathyroid tumour benign, . METHOTREXATE dosage: unknown. Patient recovered.
BILE DUCT CANCER : Zyrtec Side Effects Report #5398208-4
ZYRTEC problem was reported by a Consumer or non-health professional from BELGIUM on July 19, 2007. Male patient, 38 years of age, was diagnosed with hypersensitivity and was treated with ZYRTEC. After drug was administered, patient experienced the following problems/side effects: bile duct cancer, . ZYRTEC dosage: DAILY DOSE:10MG. Patient recovered.
BILE DUCT CANCER : Mirtazapine Side Effects Report #5401333-2
Consumer or non-health professional from UNITED KINGDOM reported MIRTAZAPINE problem on July 17, 2007. Female patient, 47 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: bile duct cancer, . MIRTAZAPINE dosage: 30 MG, QD, ORAL. During the same period patient was treated with ESCITALOPRAM OXALATE, LANSOPRAZOLE, METOCLOPRAMIDE. Patient recovered.
BILE DUCT CANCER : Mirtazapine Side Effects Report #5402818-5
MIRTAZAPINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on July 17, 2007. Female patient, 47 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: bile duct cancer, . MIRTAZAPINE dosage: 30 MG, ORAL. During the same period patient was treated with ESCITALOPRAM OXALATE, LANSOPRAZOLE, METOCLOPRAMIDE. Patient recovered.
BILE DUCT CANCER : Mirtazapine Side Effects Report #5403564-4
Consumer or non-health professional from UNITED KINGDOM reported MIRTAZAPINE problem on July 17, 2007. Female patient, 47 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: bile duct cancer, . MIRTAZAPINE dosage: 30 MG;QD;PO. During the same period patient was treated with ESCITALOPRAM OXALATE, METOCLOPRAMIDE, LANSOPRAZOLE. Patient recovered.
BILE DUCT CANCER : Mirtazapine Side Effects Report #5404664-5
MIRTAZAPINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on July 17, 2007. Female patient, 47 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: bile duct cancer, . MIRTAZAPINE dosage: (30 MG). Patient recovered.
BILE DUCT CANCER : Lapatinib Side Effects Report #5380794-1
Physician from GERMANY reported LAPATINIB problem on June 28, 2007. Female patient, 55 years of age, weighting 147.7 lb, was treated with LAPATINIB. After drug was administered, patient experienced the following problems/side effects: bile duct cancer, cholestasis, hyperbilirubinaemia, jaundice, . LAPATINIB dosage: 1250MG PER DAY. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient recovered.
BILE DUCT CANCER : Enbrel Side Effects Report #5385915-2
ENBREL problem was reported by a Physician from GERMANY on July 04, 2007. Female patient, weighting 198.4 lb, was diagnosed with rheumatoid arthritis and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: bile duct cancer, femoral neck fracture, heparin-induced thrombocytopenia, multi-organ failure, pancreatitis necrotising, pancytopenia, pyrexia, sepsis, ventricular fibrillation, . ENBREL dosage: unknown. During the same period patient was treated with METHOTREXATE, PREDNISOLONE, MARCUMAR, BISOPROLOL, XIPAMIDE, MORPHINE. Patient was hospitalized. Patient died on 03/19/2007.
BILE DUCT CANCER : Mirtazapine Side Effects Report #5395628-9
Health Professional from UNITED KINGDOM reported MIRTAZAPINE problem on July 17, 2007. Female patient, 41 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: bile duct cancer, . MIRTAZAPINE dosage: 30 MG QD ORAL. During the same period patient was treated with ESCITALOPRAM OXALATE, LANSOPRAZOLE, METOCLOPRAMIDE. Patient recovered.
BILE DUCT CANCER : Methotrexate Side Effects Report #5396850-8
METHOTREXATE problem was reported by a Consumer or non-health professional from FINLAND on July 24, 2007. Female patient, 52 years of age, was diagnosed with psoriatic arthropathy and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: bile duct cancer, parathyroid tumour benign, . METHOTREXATE dosage: unknown. Patient recovered.
BILE DUCT CANCER : Zyrtec Side Effects Report #5398208-4
Consumer or non-health professional from BELGIUM reported ZYRTEC problem on July 19, 2007. Male patient, 38 years of age, was diagnosed with hypersensitivity and was treated with ZYRTEC. After drug was administered, patient experienced the following problems/side effects: bile duct cancer, . ZYRTEC dosage: DAILY DOSE:10MG. Patient recovered.
BILE DUCT CANCER : Mirtazapine Side Effects Report #5401333-2
MIRTAZAPINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on July 17, 2007. Female patient, 47 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: bile duct cancer, . MIRTAZAPINE dosage: 30 MG, QD, ORAL. During the same period patient was treated with ESCITALOPRAM OXALATE, LANSOPRAZOLE, METOCLOPRAMIDE. Patient recovered.
BILE DUCT CANCER : Mirtazapine Side Effects Report #5402818-5
Consumer or non-health professional from UNITED KINGDOM reported MIRTAZAPINE problem on July 17, 2007. Female patient, 47 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: bile duct cancer, . MIRTAZAPINE dosage: 30 MG, ORAL. During the same period patient was treated with ESCITALOPRAM OXALATE, LANSOPRAZOLE, METOCLOPRAMIDE. Patient recovered.
BILE DUCT CANCER : Mirtazapine Side Effects Report #5403564-4
MIRTAZAPINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on July 17, 2007. Female patient, 47 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: bile duct cancer, . MIRTAZAPINE dosage: 30 MG;QD;PO. During the same period patient was treated with ESCITALOPRAM OXALATE, METOCLOPRAMIDE, LANSOPRAZOLE. Patient recovered.
BILE DUCT CANCER : Mirtazapine Side Effects Report #5404664-5
Consumer or non-health professional from UNITED KINGDOM reported MIRTAZAPINE problem on July 17, 2007. Female patient, 47 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: bile duct cancer, . MIRTAZAPINE dosage: (30 MG). Patient recovered.
BILE DUCT CANCER : Abatacept Side Effects Report #5584544-5
ABATACEPT problem was reported by a Health Professional from UNITED STATES on Jan 07, 2008. Female patient, 53 years of age, was diagnosed with rheumatoid arthritis and was treated with ABATACEPT. After drug was administered, patient experienced the following problems/side effects: abdominal pain, bile duct cancer, . ABATACEPT dosage: unknown. During the same period patient was treated with ORENCIA, METHOTREXATE, PERCOCET, ADVAIR DISKUS, CELEXA, CELEBREX, PREDNISONE, FOLIC ACID. Patient was hospitalized. Patient recovered.
BILE DUCT CANCER : Abatacept Side Effects Report #5598873-2
Health Professional from UNITED STATES reported ABATACEPT problem on Jan 16, 2008. Female patient, 53 years of age, was diagnosed with rheumatoid arthritis and was treated with ABATACEPT. After drug was administered, patient experienced the following problems/side effects: abdominal pain, bile duct cancer, . ABATACEPT dosage: unknown. During the same period patient was treated with METHOTREXATE, ORENCIA, PERCOCET, ADVAIR DISKUS, CELEXA, CELEBREX, PREDNISONE, FOLIC ACID. Patient was hospitalized. Patient recovered.
BILE DUCT CANCER : Abatacept Side Effects Report #5566729-7
ABATACEPT problem was reported by a Health Professional from UNITED STATES on Dec 14, 2007. Female patient, 53 years of age, was diagnosed with rheumatoid arthritis and was treated with ABATACEPT. After drug was administered, patient experienced the following problems/side effects: abdominal pain, bile duct cancer, . ABATACEPT dosage: unknown. During the same period patient was treated with ORENCIA, METHOTREXATE, PERCOCET, ADVAIR DISKUS, CELEXA, CELEBREX, PREDNISONE, FOLIC ACID. Patient was hospitalized. Patient recovered.
BILE DUCT CANCER : Abatacept Side Effects Report #5576938-9
Health Professional from UNITED STATES reported ABATACEPT problem on Dec 26, 2007. Female patient, 53 years of age, was diagnosed with rheumatoid arthritis and was treated with ABATACEPT. After drug was administered, patient experienced the following problems/side effects: abdominal pain, bile duct cancer, . ABATACEPT dosage: unknown. During the same period patient was treated with ORENCIA, METHOTREXATE, PERCOCET, ADVAIR DISKUS, CELEXA, CELEBREX, PREDNISONE, FOLIC ACID. Patient was hospitalized. Patient recovered.
BILE DUCT CANCER : Abatacept Side Effects Report #5530226-5
ABATACEPT problem was reported by a Health Professional from UNITED STATES on Nov 19, 2007. Female patient, 53 years of age, was diagnosed with rheumatoid arthritis and was treated with ABATACEPT. After drug was administered, patient experienced the following problems/side effects: abdominal pain, bile duct cancer, . ABATACEPT dosage: unknown. During the same period patient was treated with ORENCIA, METHOTREXATE, PERCOCET, ADVAIR DISKUS, CELEXA, CELEBREX, PREDNISONE, FOLIC ACID. Patient was hospitalized. Patient recovered.
BILE DUCT CANCER : Simvastatin Side Effects Report #5477542-3
Health Professional from UNITED KINGDOM reported SIMVASTATIN problem on July 26, 2007. Male patient, 83 years of age, weighting 99.65 lb, was treated with SIMVASTATIN. After drug was administered, patient experienced the following problems/side effects: back pain, bile duct cancer, decreased appetite, mobility decreased, rhabdomyolysis, . SIMVASTATIN dosage: 40 MG, ORAL. During the same period patient was treated with ASPIRIN, ATENOLOL, DOXAZOSIN MESYLATE, EPROSARTAN, FLUTICASONE PROPIONATE, LEVOTHYROXINE, NICARDIPINE. Patient was hospitalized. Patient recovered.
BILE DUCT CANCER : Avonex Side Effects Report #5457947-7
AVONEX problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 10, 2007. Female patient, 48 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: adenocarcinoma, bile duct cancer, blood albumin decreased, blood alkaline phosphatase increased, dehydration, dizziness, hepatic neoplasm malignant, hypotension, sepsis, . AVONEX dosage: unknown. During the same period patient was treated with AMANTADINE, COZAAR, ANTIVERT, LASIX, CYMBALTA, THYROID MED. Patient was hospitalized. Patient recovered.
BILE DUCT CANCER : Metformin Side Effects Report #5472178-2
Physician from UNITED STATES reported METFORMIN problem on Sept 18, 2007. Male patient, 54 years of age, was diagnosed with type 2 diabetes mellitus and was treated with METFORMIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, bile duct cancer, bile duct stenosis, coronary artery disease, coronary artery occlusion, granuloma, hepatic lesion, lymphoma, neoplasm malignant, . METFORMIN dosage: 2000 MG (1000 MG, 2 IN 1 D) PO. During the same period patient was treated with ASPIRIN, ACCUPRIL, LESCOL, ACETAMINOPHEN, CIALIS. Patient was hospitalized. Patient recovered.
BILE DUCT CANCER : Simvastatin Side Effects Report #5409421-1
SIMVASTATIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on July 26, 2007. Male patient, 83 years of age, weighting 99.65 lb, was treated with SIMVASTATIN. After drug was administered, patient experienced the following problems/side effects: back pain, bile duct cancer, decreased appetite, fatigue, mobility decreased, rhabdomyolysis, . SIMVASTATIN dosage: 40 MG, ORAL. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, ATENOLOL, DOXAZOSIN, EPROSARTAN, FLUTICASONE PROPIONATE, LEVOTHYROXINE, NICARDIPINE. Patient was hospitalized. Patient recovered.
BILE DUCT CANCER : Simvastatin Side Effects Report #5412619-X
Consumer or non-health professional from UNITED KINGDOM reported SIMVASTATIN problem on July 26, 2007. Male patient, 83 years of age, was treated with SIMVASTATIN. After drug was administered, patient experienced the following problems/side effects: back pain, bile duct cancer, decreased appetite, fatigue, mobility decreased, rhabdomyolysis, . SIMVASTATIN dosage: (40 MG). Patient was hospitalized. Patient recovered.
BILE DUCT CANCER : Zocor Side Effects Report #5401950-X
ZOCOR problem was reported by a Health Professional from UNITED KINGDOM on July 26, 2007. Male patient, 83 years of age, weighting 99.21 lb, was treated with ZOCOR. After drug was administered, patient experienced the following problems/side effects: back pain, bile duct cancer, decreased appetite, fatigue, mobility decreased, rhabdomyolysis, . ZOCOR dosage: unknown. During the same period patient was treated with ASPIRIN, ATENOLOL, DOXAZOSIN MESYLATE, EPROSARTAN, FLUTICASONE PROPIONATE, LEVOTHYROXINE, NICARDIPINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
BILE DUCT CANCER : Zocor Side Effects Report #5401950-X
Health Professional from UNITED KINGDOM reported ZOCOR problem on July 26, 2007. Male patient, 83 years of age, weighting 99.21 lb, was treated with ZOCOR. After drug was administered, patient experienced the following problems/side effects: back pain, bile duct cancer, decreased appetite, fatigue, mobility decreased, rhabdomyolysis, . ZOCOR dosage: unknown. During the same period patient was treated with ASPIRIN, ATENOLOL, DOXAZOSIN MESYLATE, EPROSARTAN, FLUTICASONE PROPIONATE, LEVOTHYROXINE, NICARDIPINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.